Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)

China flag China · Delayed Price · Currency is CNY
14.16
-0.01 (-0.07%)
At close: Mar 9, 2026
-17.58%
Market Cap 8.09B
Revenue (ttm) 1.81B
Net Income (ttm) 24.02M
Shares Out 571.39M
EPS (ttm) 0.04
PE Ratio 336.85
Forward PE 20.40
Dividend 0.21 (1.48%)
Ex-Dividend Date Jun 27, 2025
Volume 4,610,064
Average Volume 5,299,020
Open 14.07
Previous Close 14.17
Day's Range 13.93 - 14.29
52-Week Range 13.51 - 17.68
Beta 0.54
RSI 50.37
Earnings Date Apr 29, 2026

About Shenzhen YHLO Biotech

Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. The company offers chemiluminescence immunoassay analyzer, diabetes solution, automated biochemical analyzer, laboratory automation, tenfly phoenix blot analyzer, VISION Pro ESR analyzer, and VISION ESR analyzer. The company was founded in 2008 and is headquartered in Shenzhen, China. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2008
Employees 1,678
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688575
Full Company Profile

Financial Performance

In 2025, Shenzhen YHLO Biotech's revenue was 1.81 billion, a decrease of -10.07% compared to the previous year's 2.01 billion. Earnings were 24.02 million, a decrease of -92.03%.

Financial Statements

News

There is no news available yet.